» Articles » PMID: 1259387

Pharmacological Studies with Cefamandole in Human Volunteers

Overview
Specialty Pharmacology
Date 1976 Jan 1
PMID 1259387
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Serum and urine concentrations were measured after administration of 0.5-and 1-g doses of cefamandole intramuscularly and intravenously to healthy volunteers. Intramuscular doses of 0.5 and 1 g yielded serum concentrations at 1 h of 14.7 and 35.6 mug/ml, respectively. Significant antibacterial concentrations persisted through h 8. Intravenous doses of 0.5 and 1 g resulted in respective peak serum levels of 21 mug/ml at 45 min and 103 mug/ml at 15 min; these serum levels rapidly declined. Very high urine concentrations were achieved during the first 8 h after injection.

Citing Articles

Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.

SNYDER N, Tabas L, Berry D, Duckworth D, Spry D, Dantzig A Antimicrob Agents Chemother. 1997; 41(8):1649-57.

PMID: 9257735 PMC: 163979. DOI: 10.1128/AAC.41.8.1649.


Pharmacokinetics of cefamandole in osseous tissue.

Lunke R, Fitzgerald Jr R, Washington 2nd J Antimicrob Agents Chemother. 1981; 19(5):851-8.

PMID: 7294769 PMC: 181534. DOI: 10.1128/AAC.19.5.851.


Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.

De Girolami P, Maher L, Booth M, St George D J Clin Microbiol. 1980; 12(4):546-9.

PMID: 6999021 PMC: 273633. DOI: 10.1128/jcm.12.4.546-549.1980.


The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.

Fernandez Lastra C, Marino E, Dominguez-Gil A, Tabernero J, Gonzalez Lopez A, Yuste Chaves M Eur J Clin Pharmacol. 1983; 25(3):333-8.

PMID: 6628521 DOI: 10.1007/BF01037944.


Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.

Bliss M, Mayersohn M, Arnold T, Logan J, Michael U, Jones W Antimicrob Agents Chemother. 1986; 29(4):649-53.

PMID: 3707113 PMC: 180460. DOI: 10.1128/AAC.29.4.649.


References
1.
Nicholas P, Meyers B, Hirschman S . Pharmacology of cefazolin in human volunteers. J Clin Pharmacol. 1973; 13(8):325-31. DOI: 10.1002/j.1552-4604.1973.tb00219.x. View

2.
Meyers B, Hirschman S, Nicholas P . Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother. 1972; 2(4):250-4. PMC: 444301. DOI: 10.1128/AAC.2.4.250. View

3.
Eykyn S, Jenkins C, King A, Phillips I . Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973; 3(6):657-61. PMC: 444475. DOI: 10.1128/AAC.3.6.657. View

4.
Neu H . Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974; 6(2):177-82. PMC: 444624. DOI: 10.1128/AAC.6.2.177. View

5.
Meyers B, Leng B, Hirschman S . Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother. 1975; 8(6):737-41. PMC: 429456. DOI: 10.1128/AAC.8.6.737. View